Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Grail test is a POS
View:
Post by Photoman77 on Sep 13, 2021 1:25pm

Grail test is a POS

https://news.harvard.edu/gazette/story/2020/03/in-clinical-study-blood-test-can-detect-range-of-cancers/ 

"In a study involving thousands of participants, a new blood test (Grail) detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute, a Harvard affiliate, and the Mayo Clinic."

Here is the problem ^^


39 percent sensitivity for patients with stage I cancer
69 percent sensitivity for those with stage II cancer
83 percent sensitivity for those with stage III cancer
92 percent sensitivity for those with stage IV cacner

39% stage 1 is terrible for Grail! That's worse that a grade F in school.

Aristotle is far superior with over 90% accuracy at this stage for most common cancers

Grail for 8 billion dolalrs lol!
Comment by LithLover on Sep 13, 2021 1:30pm
Maybe Grail can change their name to StageFour Life Sciences
Comment by IainCaimbeul on Sep 13, 2021 1:45pm
For Grail maybe Dead Man Walking Sciences.
Comment by Nailbiter1 on Sep 13, 2021 2:22pm
This post has been removed in accordance with Community Policy